The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 06, 2021
Filed:
Feb. 27, 2018
Applicant:
Glaxosmithkline Intellectual Property (No.2) Limited, Brentford, GB;
Inventors:
Stephen John Atkinson, Stevenage, GB;
Emmanuel Hubert Demont, Stevenage, GB;
Lee Andrew Harrison, Stevenage, GB;
Gemma Michele Liwicki, Stevenage, GB;
Simon Christopher Cranko Lucas, Stevenage, GB;
Alexander G. Preston, Stevenage, GB;
Jonathan Thomas Seal, Stevenage, GB;
Ian David Wall, Stevenage, GB;
Robert J. Watson, Stevenage, GB;
Assignee:
GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED, Middlesex, GB;
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4155 (2006.01); C07D 405/12 (2006.01); A61K 31/415 (2006.01); C07D 231/14 (2006.01); C07D 403/12 (2006.01); C07D 471/04 (2006.01); A61K 31/437 (2006.01); A61K 31/4439 (2006.01); C07D 401/12 (2006.01); A61K 31/422 (2006.01); C07D 413/12 (2006.01); A61K 31/5377 (2006.01); C07D 405/14 (2006.01); C07D 417/12 (2006.01); A61K 31/4192 (2006.01); A61K 31/4184 (2006.01); A61K 31/4245 (2006.01); A61K 31/433 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4155 (2013.01); A61K 31/415 (2013.01); A61K 31/4184 (2013.01); A61K 31/4192 (2013.01); A61K 31/422 (2013.01); A61K 31/4245 (2013.01); A61K 31/433 (2013.01); A61K 31/437 (2013.01); A61K 31/4439 (2013.01); A61K 31/5377 (2013.01); C07D 231/14 (2013.01); C07D 401/12 (2013.01); C07D 403/12 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 413/12 (2013.01); C07D 417/12 (2013.01); C07D 471/04 (2013.01);
Abstract
The present invention is directed to pyrazole derivatives, pharmaceutical compositions comprising the compounds and the use of the compounds or the compositions in the treatment of various diseases.